Aaron Sulkes

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Drug Therapy 76%
3. Neoplasms 56%
4. Radiotherapy 48%
5. Fluorouracil 46%
6. Doxorubicin 42%
7. Israel 38%
8. Survival 36%
9. Colorectal Neoplasms 32%
10. Cisplatin 32%
11. Stomach Neoplasms 32%
12. Therapeutics 28%
13. Melanoma 27%
14. Merkel Cell Carcinoma 26%
15. Rectal Neoplasms 25%
16. Cyclophosphamide 24%
17. Neoplasm Metastasis 23%
18. Carcinoma 23%
19. Recurrence 22%
20. Docetaxel 21%
21. Combination Drug Therapy 20%
22. Jews 20%
23. Capecitabine 19%
24. Adjuvant Chemotherapy 18%
25. Methotrexate 18%
26. Radiation 18%
27. Esophageal Neoplasms 17%
28. Leucovorin 16%
29. Chemoradiotherapy 16%
30. Prospective Studies 16%
31. Liposomes 15%
32. Disease-Free Survival 15%
33. Dacarbazine 14%
34. Kaposi's Sarcoma 13%
35. Vinblastine 13%
36. Clinical Studies 13%
37. Positron Emission Tomography Computed Tomography 12%
38. Mutation 12%
39. Airway Obstruction 12%
40. Survival Rate 12%
41. Transcobalamins 11%
42. Aminoglutethimide 11%
43. Brachytherapy 11%
44. Second Primary Neoplasms 10%
45. Squamous Cell Carcinoma 10%
46. Adenocarcinoma 10%
47. Pharmaceutical Preparations 10%
48. Trastuzumab 10%
49. Pharmacokinetics 10%
50. Androgens 9%